Flomax and Hypertrophy - a phase IV clinical study of FDA data

Summary:

Hypertrophy is reported as a side effect among people who take Flomax (tamsulosin hydrochloride), especially for people who are male, 60+ old, also take Lotensin, and have Bone loss.

The phase IV clinical study analyzes which people have Hypertrophy when taking Flomax. It is created by eHealthMe based on reports of 50,469 people who have side effects when taking Flomax from the FDA, and is updated regularly.

What is Flomax?

Flomax has active ingredients of tamsulosin hydrochloride. It is often used in enlarged prostate. eHealthMe is studying from 52,865 Flomax users. Check the latest studies of Flomax.

What is Hypertrophy?

Hypertrophy (increase in the volume of an organ or tissue due to the enlargement of its component cells) is found to be associated with 239 drugs and 292 conditions by eHealthMe. Check the latest studies of Hypertrophy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

50,469 people reported to have side effects when taking Flomax.
Among them, 11 people (0.02%) have Hypertrophy.

Among these 11 people:

What is the gender of people who have Hypertrophy when taking Flomax? *

female: 0.0 %
male: 100 %

What is the age of people who have Hypertrophy when taking Flomax? *

What are other drugs people take besides Flomax? *

What are other side effects people have besides Hypertrophy? *

Injury: 11 people, 100.00%
Pain: 11 people, 100.00%
Stress And Anxiety: 11 people, 100.00%
Vascular Calcification (deposits of calcium in the blood vessels): 9 people, 81.82%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 9 people, 81.82%
Osteonecrosis Of Jaw (death of bone of jaw): 9 people, 81.82%
Disability: 9 people, 81.82%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 9 people, 81.82%
Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 9 people, 81.82%
Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 9 people, 81.82%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 2 people, 18.18%
Bone Loss: 2 people, 18.18%
Aplastic Anemia: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Flomax and have Hypertrophy?

- Check whether Hypertrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Flomax:

Flomax (52,865 reports)

Hypertrophy treatments and more:

Hypertrophy (835 reports)

Browse all side effects of Flomax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypertrophy:

Hypertrophy (239 drugs)

Browse all the conditions that are associated with Hypertrophy:

Hypertrophy (292 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tamsulosin hydrochloride (the active ingredients of Flomax) and Flomax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.